Balram, Bhairavi http://orcid.org/0000-0001-6267-9934
Lubov, Joshua
Theoret, Yves
Afif, Waqqas
Bitton, Alain
Wild, Gary
Lakatos, Peter L.
Bessissow, Talat
Article History
Received: 14 April 2020
Accepted: 16 June 2020
First Online: 26 June 2020
Compliance with Ethical Standards
:
: T. Bessissow has received honoraria and acted as a consultant for Janssen, AbbVie, Takeda, and Pfizer and acted as speaker for Janssen, AbbVie, Takeda, Ferring, Actavis, PendoPharm, and Shire. T. Bessissow has served as a speaker, a consultant, and an advisory board member for Janssen, AbbVie, Takeda, Pfizer, Ferring, PendoPharm, Shire and has received research funding from AbbVie and Janssen. PL Lakatos has been a speaker and/or advisory board member: AbbVie, EGIS, Falk Pharma, GmbH, Ferring, Genetech, Jansen, Kyowa, Hakko Kirin Pharma, Mitsubishi Tanabe Pharma Corporation, MSD, Otsuka Pharma, Pharmacosmos, Pfizer, Roche, Shire, and Takeda and has received unrestricted grants: AbbVie, MSD, and Pfizer. Waqqas Afif has served as a speaker and/or advisory board for AbbVie, Janssen, Takeda, Merck, Pfizer, Ferring, Shire, and received research grants from AbbVie, Theradiag, and Prometheus. Alain Bitton has received honorarium for participation in advisory boards from Allergan. AlainĀ Bitton is a Consultant, Advisory Board: AbbVie, Janssen, Shire, Warner Chilcott, Takeda, and Speaker: AbbVie, Janssen, Shire, Warner Chilcott, Aptalis. GW has been a speaker and/or advisory board member for AbbVie, Janssen, Pfizer, Shire, and Takeda. B. Balram, Y. Theoret, and J. Lubov have no conflicts of interest to report.